Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2026-02-20 @ 6:33 PM
Study NCT ID:
NCT03875092
Status:
COMPLETED
Last Update Posted:
2024-10-01
First Post:
2019-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-13
First Submit QC Date:
None
Study First Post Date:
2019-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-21
Results First Submit QC Date:
None
Results First Post Date:
2021-10-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-04
Last Update Post Date:
2024-10-01
Last Update Post Date Type:
ACTUAL